Cutaneous manifestations due to Pseudomonas infection

International Journal of Dermatology

Volumn 38, Issue 6, 1999, Pages 419-431

  Silvestre, J F ^a   Betlloch, M I ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; HYDROCORTISONE; NEOMYCIN; OFLOXACIN; POLYMYXIN B; TOBRAMYCIN;

BLASTOMYCOSIS; DISEASE PREDISPOSITION; EXTERNAL OTITIS; FOLLICULITIS; GRAM NEGATIVE INFECTION; INTERTRIGO; OMPHALITIS; PATHOGENESIS; PYODERMA; REVIEW; SKIN MANIFESTATION;

HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SKIN; SKIN DISEASES, BACTERIAL;

EID: 0033066145     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00606.x     Document Type: Review

References (76)

1. Greene SL, Su WPD, Muller SA. Pseudomonas aeruginosa infections of the skin. Am Phys Pract 1984; 29: 193-100.
2. García-Patos V, Castells A. Infecciones cutâneas por Pseudomonas aeruginosa. Piel 1995; 10: 87-98.
3. Le Frock JL, Ristuccia AM. Pseudomonas aeruginosa infections in the podiatric patient. Clin Podiatr Med Surg 1990; 7: 493-500.
4. El Baze P, Lacour JP, Ortonne JP. Le Pseudomonas aeruginosa en dermatologie. Ann Dermatol Venereol 1985; 112: 925-934.
5. Pollack M. Pseudomonas aeruginosa. In: Mandell GL, et al., eds. Principles and Practice of Infectious Diseases, 3rd edn. New York: Wiley, 1990: 1673-1691.
6. Agger WA, Maradan A. Pseudomonas aeruginosa infections of intact skin. Clin Infect Dis 1995; 20: 302-308.
7. Rolston KV, Bodey GP. Pseudomonas aeruginosa infection in cancer patients. Cancer Invest 1992; 10: 43-59.
8. Noble WC, Savin JA. Gram-negative infections of the skin. Br J Dermatol 1971; 85: 286-289.
9. White PM. Pseudomonas aeruginosa in a skin hospital. Br J Dermatol 1971; 85: 412-417.
10. Hojyo-Tomoka MT, Marples RR, Kligman AM. Pseudomonas infection in superhydrated skin. Arch Dermatol 1973; 107: 723-727.
11. Bergan T. Pathogenic factors of Pseudomonas aeruginosa. Scand J Infect Dis 1981; 29 (Suppl.): 7-12.
12. Nordbring F. Pseudomonas. Clinical problems related to virulence factors and development of resistance. Arch Intern Med 1982; 142: 2010-2011.
13. Liu PV. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. J Infect Dis 1966; 116: 112-116.
14. Singh H. Pseudomonas infections of skin. An experimental study, Int J Dermatol 1974; 13: 90-93.
15. Sato H, Okinaga K, Saito H. Role of pili in the pathogenesis of Pseudomonas aeruginosa burn infection. Microbiol Immunol 1988; 32: 131-139.
16. Mull JD, Callahan WS. The role of elastase of Pseudomonas aeruginosa in experimental infection. Exp Mol Pathol 1965; 4: 567.
17. Heggers JP, Haydon S, Ko F, et al. Pseudomonas aeruginosa exotoxin A: its role in retardation of wound healing. J Burn Care Rehab 1992; 13: 512-518.
18. Gould IM, Wise R. Pseudomonas aeruginosa: clinical manifestations and management. Lancet 1985; ii: 1224-1227.
19. Bécherel PA, Chosidow O, Berger E, et al. Granulocyte-macrophage colony-stimulating factor in the management of severe ecthyma gangrenosum related to myelodysplastic syndrome. Arch Dermatol 1995; 131: 892-894.
20. Berger T, Kaveh S, Becker D, et al. Cutaneous manifestations of Pseudomonas infections in AIDS. J Am Acad Dermatol 1995; 32: 279-280.
21. Hall JH, Callaway JL, Tindall J, et al. Pseudomonas aeruginosa in dermatology. Arch Dermatol 1968; 97: 312-324.
22. Urbano P, Dei R, Tarantelli F, et al. Epidemiological studies of Pseudomonas aeruginosa infections in leg ulcers. Med Microbiol Immunol Berl 1983; 172: 41-45.
23. Pruit BA. Infections caused by Pseudomonas species in patients with burns and other surgical patients. J Infect Dis 1974; 130 (Suppl.): 58-64.
24. Jones RJ, Roe EA, Gupta JL. Controlled trials of a polyvalent Pseudomonas vaccine in burns. Lancet 1979; ii: 977-982.
25. Bishop GF, Greer KE, Horwitz DA. Pseudomonas botryomycosis. Arch Dermatol 1976; 112: 1568-1570.
26. Hebert AA, Esterly NB. Bacterial and candidal cutaneous infections in the neonate. Dermatol Clin 1986; 4: 3-21.
27. Abramson C. Athlete's foot caused by Pseudomonas aeruginosa. Clin Dermatol 1983; 1: 14-24.
28. Leyden JJ, Kligman AM. Interdigital athlete's foot. The interaction of dermatophytes and resident bacteria. Arch Dermatol 1978; 114: 1466-1472.
29. Cho S, Westfried M, Lynfield Y. Immersion foot: an occupational disease. Cutis 1980; 25: 662.
30. Eaglstein NF, Marley WM, Marley NF. Gram-negative toeweb infection: successful treatment with a new third generation cephalosporin. J Am Acad Dermatol 1983; 8: 225-228.
31. Fachin-Viso R. Uñas verdes. Med Cut Iber Lat Am 1974; 3: 175-178.
32. Chernosky ME, Dukes CD. Green nails. Importance of Pseudomonas aeruginosa in onychia. Arch Dermatol 1963; 88: 548-554.
33. Stone OJ, Mullins JF. The role of Pseudomonas aeruginosa in nail disease. J Invest Dermatol 1963; 41: 15-16.
34. LeFeber WP, Golitz LE. Green foot. Pediatr Dermatol 1984; 2: 38-40.
35. Lacour JP, El Baze P, Castanet J, et al. Diving suit dermatitis caused by Pseudomonas aeruginosa. J Am Acad Dermatol 1994; 31: 1055-1056.
36. Berger RS, Seifert MR. Whirlpool folliculitis: a review of its cause, treatment and prevention. Cutis 1990; 45: 97-98.
37. Highsmith AK, Khabbaz RF, Munn VP. Characteristics of Pseudomonas aeruginosa isolated from whirlpools and bathers. Infect Control 1985; 6: 407-412.
38. Maniatis AN, Karkavitsas C, Maniatis NA, et al. Pseudomonas aeruginosa folliculitis due to non-O-11 serogroups: acquisition through use of contaminated synthetic sponges. Clin Infect Dis 1995; 21: 437-439.
39. Bottone EJ, Perez AA. Pseudomonas aeruginosa folliculitis acquired through use of a contaminated loofah sponge: an unrecognized potential public health problem. J Clin Microbiol 1993; 31: 480-483.
40. Schlech WF III, Simonsen N, Sumarah R, et al. Nosocomial outbreak of Pseudomonas aeruginosa folliculitis associated with a physiotherapy pool. Can Med Assoc J 1986; 134: 909-913.
41. El Baze P, Thyss A, Aldani C, et al. Pseudomonas aeruginosa O-11 folliculitis. Development into ecthyma gangrenosum in immunosuppressed patients. Arch Dermatol 1985; 121: 873-876.
42. Smith GL. Methods for preventing Pseudomonas folliculitis. Cutis 1982; 29: 378-381.
43. De la Cuadra J, Gil-Mateo P, Llucian R. Pseudomonas aeruginosa folliculitis after depilation. Ann Dermatol Venereol 1996; 123: 268-270.
44. Tomás S, Torné J, Carcía J. Foliculitis por Pseudomonas aeruginosa en personal hospitalario femenino tras le depilaci'n por cera. Rev Clin Esp 1990; 186: 193.
45. Leyden JJ, McGinley KJ, Mills OH. Pseudomonas aeruginosa Gram-negative folliculitis. Arch Dermatol 1979; 115: 1203-1204.
46. Sundström J, Jacobson K, Munck-Wikland E, et al. Pseudomonas in otitis externa. A particular variety of the bacteria? Arch Otolaryngol Head Neck Surg 1996; 122: 833-836.
47. Agius AM, Pickles JM, Burch KL. A prospective study of otitis externa. Clin Otolaryngol 1991; 17: 150-154.
48. Kielhofner M, Atmar RL, Hamill RJ, et al. Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis 1992; 14: 403-411.
49. Rubinstein E, Ostfeld E, Ben-Zaray S, et al. Necrotizing external otitis. Pediatrics 1980; 66: 618-620.
50. Petrozzi JW, Erlich A. Pseudomonal balanitis. Arch Dermatol 1977; 113: 952-953.
51. Juster-Reicher A, Mogilner BM, Levi G, et al. Neonatal noma. Am J Perinatol 1993; 10: 409-411.
52. Lepaw MI. Therapy and histopathology of complications from synthetic fiber implants for hair replacement. A presentation of one hundred cases. J Am Acad Dermatol 1980; 3: 195-204.
53. Ramesh V. Dissecting cellulitis of the scalp in 2 girls. Dermatologica 1980; 180: 48-50.
54. Keren G, Cohen BE, Barzilay Z, et al. Kawasaki's disease and infantile polyarteritis nodosa: is Pseudomonas infection responsible: Israel J Med Sci 1979; 15: 592-600.
55. Dorff GJ, Geimer NF, Rosenthal DR, et al. Pseudomonas septicemia. Illustrated evolution of its skin lesion. Arch Intern Med 1971; 128: 591-595.
56. Silvestre JF, Betlloch I, Morell AM, et al. Manifestaciones cutáneas de la sepsis por Pseudomonas aeruginosa. Actas Dermosifiliogr 1997; 88: 19-22.
57. Sangeorzan JA, Bradley JF, Kauffman CA. Cutaneous manifestations of Pseudomonas infection in the acquired immunodeficiency syndrome. Arch Dermatol 1990; 126: 832-833.
58. Flores G, Stavola JJ, Noel GJ. Bacteremia due to Pseudomonas aeruginosa in children with aids. Clin Infect Dis 1993; 16: 706-708.
59. Schaberg DN, Turck M. Diseases caused by Gram-negative enteric bacilli. In: Wilson JD, Braunwald E, Isselbacher KS, et al., eds. Harrison's Principles of Internal Medicine, 12th edn. New York: McGraw-Hill, 1991: 603-605.
60. Llistosella E, Ravella A, Moreno A, de Moragas JM. Panniculitis in Pseudomonas aeruginosa septicemia. Acta Derm Venereol (Stockh) 1984; 64: 447-449.
61. Fleming MG, Milburn PB, Prose NS. Pseudomonas septicemia with nodules and bullae. Pediatric Dermatol 1987; 4: 18-20.
62. Bagel J, Grosman ME. Subcutaneous nodules in Pseudomonas sepsis. Am J Med 1986; 80: 528-529.
63. Taieb A, Boisseau AM, Sarlangue J, et al. Ecthyma gangreneux du siege du nourrisson. Ann Pediatr Paris 1992; 39: 443-446.
64. El Baze F, Thyss A, Vinti H, et al. A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol (Stockh) 1991; 71: 411-415.
65. Boisseau AM, Sarlengu J, Perel Y, et al. Perineal ecthyma gangrenosum in infancy and early childhood: septicemic and nonsepticemic forms. J Am Acad Dermatol 1992; 27: 415-418.
66. Greene SL, Su WP, Muller SA. Ecthyma gangrenosum: report of clinical, histopathologic, and bacterial aspects of eight cases. J Am Acad Dermatol 1984; 11: 781-787.
67. Korten V, Gurbuz O, Firatli T, et al. Subcutaneous nodules caused by Pseudomonas aeruginosa: healing without incision and drainage. J Chemother 1992; 4: 225-227.
68. Schlossberg D. Multiple erythematous nodules as a manifestation of Pseudumonas aeruginosa septicemia. Arch Dermatol 1980; 116: 446-447.
69. Campo RE, Ratzan KR, Melnick SJ. Subcutaneous nodules as a dermatologic manifestation of bacteremia due to Pseudomonas aeruginosa. South Med J 1994; 87: 233-235.
70. Reed RK, Carter WE, Sieber OF, et al. Peripheral nodular lesions of Pseudomonas sepsis: the importance of incision and drainage. J Pediatr 1976; 88: 977-979.
71. Sloss JM, Cumberland N, Milner SM. Acetic acid used for the elimination of Pseudomonas aeruginosa from burn and soft tissue wounds. J R Army Med Corps 1993; 139: 49-51.
72. Noble WC. Gram-negative bacterial skin infections. Semin Dermatol 1993; 12: 336-341.
73. Follath F, Bindschedler M, Wenk M, et al. Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. Eur J Clin Microbiol 1986; 5: 136-140.
74. Gentry LO, Rodríguez-Gómez G. Ofloxacin treatment of difficult infections of the skin and skin structure. Cutis 1993; 51: 55-58.
75. Gentry LO. Review of quinolones in the treatment of infections of the skin and skin structure. J Antimicrob Chemother 1991; 28 (Suppl. C): 97-110.
76. Gentry LO, Rodríguez-Gómez G. Ofloxacin treatment of difficult infections of the skin and skin structure. Cutis 1993; 51: 55-58.